David P. Meeker is CEO & President at RHYTHM PHARMACEUTICALS, INC. (RYTM). They have made 10 open-market trades across 3 companies since 2008, most recently 2026-09-14.
CIK 0001385155
4 open-market purchases totalling $1.0M since 2009, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| RYTM | SELL · 10b5-1 | 2026-09-14 | 2026-09-14 | $102.67 | $5.1M | -1.7% | -13.3% | — |
| RYTM | SELL · 10b5-1 | 2025-06-03 | 2025-06-05 | $65.04 | $5.7M | -6.4% | +0.2% | +53.5% |
| RYTM | SELL · 10b5-1 | 2025-02-19 | 2025-02-19 | $57.22 | $1.1M | -9.4% | -10.0% | +10.5% |
| RYTM | SELL | 2025-02-04 | 2025-02-04 | $59.43 | $508K | -6.2% | -14.5% | +6.6% |
| TRVI | SELL | 2024-08-27 | 2024-08-29 | $2.93 | $13K | +6.8% | +8.1% | -8.7% |
| RYTM | SELL | 2024-03-19 | 2024-03-19 | $39.22 | $3.6M | +9.9% | -1.9% | +6.0% |
| RYTM | SELL | 2024-02-01 | 2024-02-05 | $45.06 | $393K | +10.0% | -10.5% | -4.4% |
| RYTM | BUY | 2021-03-30 | 2021-03-31 | $20.17 | $403K | -10.4% | -6.5% | -12.6% |
| TRVI | BUY | 2019-05-09 | 2019-05-13 | $10.00 | $113K | +12.5% | +3.2% | -36.4% |
| RYTM | BUY | 2017-10-10 | 2017-10-10 | $17.00 | $425K | -12.2% | -16.3% | +5.8% |
| GENZ | SELL | 2010-05-25 | 2010-05-26 | $45.60 | $125K | N/A | N/A | N/A |
| GENZ | SELL · 10b5-1 | 2010-05-21 | 2010-05-25 | $49.06 | $809K | N/A | N/A | N/A |
| GENZ | BUY | 2009-04-23 | 2009-04-24 | $51.95 | $104K | N/A | N/A | N/A |
| GENZ | SELL | 2008-08-15 | 2008-08-18 | $83.19 | $1.5M | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.